Hll Medipark Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 7.12 Cr
as on 16-12-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 14.56%
(FY 2021)
- Profit -9.66%
(FY 2021)
- Ebitda 0.05%
(FY 2021)
- Net Worth -19.38%
(FY 2021)
- Total Assets 7.88%
(FY 2021)
About Hll Medipark
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 7.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Hll Medipark Limited India are Nagasundaram Thiagarajan as COMPANY SECRETARY and Reddy as Ceo. Mandeep Bhandari, Roli Singh, Dharmendra Gangwar, and Four other members serve as directors at the Company.
- CIN/LLPIN
U74999KL2016GOI047562
- Company No.
047562
- Company Classification
Private Limited Union Government Company
- Incorporation Date
20 Dec 2016
- Date of AGM
30 Dec 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Hll Medipark?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagasundaram Thiagarajan  | Company Secretary | 03-Jan-2017 | Current |
| Jaya Reddy | CEO | 15-Jun-2023 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dharmendra Gangwar | Nominee Director | 02-Apr-2019 | Current |
| Mandeep Bhandari | Nominee Director | 02-Apr-2019 | Current |
| Roli Singh | Nominee Director | 21-Jun-2022 | Current |
| Jaideep Mishra | Nominee Director | 18-Oct-2022 | Current |
| Jitendra Nagar | Additional Director | 25-Mar-2022 | Current |
| Jaya Reddy | Nominee Director | 30-Nov-2023 | Current |
Financial Performance and Corporate Structure Insights of Hll Medipark.
Hll Medipark Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 14.56% increase. The company also saw a slight decrease in profitability, with a 9.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hll Medipark?
In 2021, Hll Medipark had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hll Medipark?
Unlock and access historical data on people associated with Hll Medipark, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hll Medipark, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hll Medipark's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
